{"id":"W1853197421","doi":"10.1160/th15-03-0222","title":"Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants","year":2015,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Bayer HealthCare; Janssen Scientific Affairs","keywords":"Medicine; Vitamin K antagonist; Rivaroxaban; Stroke (engine); Atrial fibrillation; Anticoagulant; Intensive care medicine; Vitamin k; Clinical trial; Gastrointestinal bleeding; Apixaban; Warfarin; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000401643,0.0001273899,0.0004449727,0.0001415581,0.00004232759,0.0000268037,0.00003943926,0.00005420372,0.00002797227],"category_scores_gemma":[0.00004779603,0.00011061,0.00005129858,0.0002573396,0.00005719429,0.0001660153,0.0001154196,0.00006935235,0.000009985604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005189121,"about_ca_system_score_gemma":0.00001849584,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006638063,"about_ca_topic_score_gemma":0.000007376027,"domain_scores_codex":[0.9989046,0.00003003865,0.0003410481,0.0002087458,0.0003152611,0.0002003035],"domain_scores_gemma":[0.9995084,0.00004059562,0.0001142709,0.0001534305,0.00007028478,0.0001130469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002026668,0.00006678604,0.9831498,0.0001531645,0.0001587587,0.00000806536,0.0002763563,0.000002000393,0.00006556263,0.0004752741,0.001619642,0.01382197],"study_design_scores_gemma":[0.004247445,0.0002002003,0.9923257,0.0002245457,0.0002128349,0.000001078339,0.0009958721,0.0002008518,0.000616271,0.00004847922,0.0008064039,0.0001203583],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932897,0.00002288919,0.0001279734,0.001818516,0.0001402716,0.000407537,0.000004552407,0.00001910232,0.004169474],"genre_scores_gemma":[0.9912189,0.0003778251,0.008115614,0.00007435849,0.00004846842,0.000001505319,0.00002484909,0.00001437653,0.0001241418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01370161,"threshold_uncertainty_score":0.4510547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2106055776287928,"score_gpt":0.4124290136840052,"score_spread":0.2018234360552124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}